Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$1.35 USD
-0.03 (-2.17%)
Updated Aug 9, 2024 01:23 PM ET
2-Buy of 5 2
F Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.43 |
Last EPS Surprise | -2.38% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.90 |
Next Year | -2.14 |
EPS (TTM) | -1.65 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 0.80M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.44 | -1.90 | -2.14 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.38 | -0.38 | -1.53 | -1.54 |
High Estimate | -0.38 | -0.37 | -1.53 | -1.54 |
Low Estimate | -0.48 | -0.50 | -2.32 | -2.68 |
Year ago EPS | -0.37 | -0.45 | -1.91 | -1.90 |
Year over Year Growth Est. | -16.22% | 2.22% | 0.52% | -12.81% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.44 | -1.90 | -2.14 |
7 Days Ago | -0.43 | -0.44 | -1.90 | -2.14 |
30 Days Ago | -0.43 | -0.44 | -1.90 | -2.14 |
60 Days Ago | -0.53 | -0.54 | -2.08 | -2.27 |
90 Days Ago | -0.64 | -0.63 | -2.47 | -2.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.44 | -1.90 | -2.14 |
Zacks Consensus Estimate | -0.43 | -0.44 | -1.90 | -2.14 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.43 | -0.40 | -0.45 | -0.37 | NA |
Estimate | -0.42 | -0.64 | -0.55 | -0.62 | NA |
Difference | -0.01 | 0.24 | 0.10 | 0.25 | 0.15 |
Surprise | -2.38% | 37.50% | 18.18% | 40.32% | 23.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more